Md. Talat Nasim

发表

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension

Graham M Lord, M. Humbert, R. Trembath, 2011, Human mutation.

Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control.

E. Tremoli, M. Brioschi, C. Banfi, 2015, Journal of proteomics.

Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertension.

R. Schermuly, R. Trembath, N. Morrell, 2013, American journal of respiratory cell and molecular biology.

BMPRII deficiency impairs apoptosis via the BMPRII-ALK1-BclX-mediated pathway in pulmonary arterial hypertension.

R. Trembath, N. Morrell, Md. Talat Nasim, 2019, Human molecular genetics.

A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells.

I. Eperon, Md. Talat Nasim, H. M. Chowdhury, 2002, Nucleic acids research.

Targeting the TGF-β signaling pathway for resolution of pulmonary arterial hypertension.

Md. Talat Nasim, N. Sharmin, Chinyere Chioma Nganwuchu, 2021, Trends in pharmacological sciences.

Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach

R. Gopalan, Md. Talat Nasim, K. Assi, 2023, Pharmaceutics.

AKAP95 regulates splicing through scaffolding RNAs and RNA processing factors

Zefeng Wang, Miaowei Mao, Md. Talat Nasim, 2016, Nature Communications.

BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.

R. Trembath, Lan Zhao, Chien-nien Chen, 2012, Human molecular genetics.

A double-reporter splicing assay for determining splicing efficiency in mammalian cells

I. Eperon, Md. Talat Nasim, 2006, Nature Protocols.

COVID-19: A natural phenomena or laboratory-based origin?

Md. Talat Nasim, Fanila Shahzad, Talat Nasim, 2020 .